Charter Oak Capital Management, LLC Gilead Sciences, Inc. Transaction History

Charter Oak Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	BUY	$57.92 - $72.58 $38,574 - $48,338	666 Added 103.42%	1,310 $78,000
Q4 2021 Feb 09, 2022	SELL	$64.88 - $73.64 $3,827 - $4,344	-59 Reduced 8.39%	644 $47,000
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $1,020 - $1,163	-17 Reduced 2.36%	703 $45,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $40,788 - $46,476	720 New	720 $42,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Charter Oak Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Charter Oak Capital Management, LLC with notifications on news.